1. Home
  2. NRSN vs PT Comparison

NRSN vs PT Comparison

Compare NRSN & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • PT
  • Stock Information
  • Founded
  • NRSN 2017
  • PT 2012
  • Country
  • NRSN Israel
  • PT China
  • Employees
  • NRSN N/A
  • PT N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • NRSN Health Care
  • PT Technology
  • Exchange
  • NRSN Nasdaq
  • PT Nasdaq
  • Market Cap
  • NRSN 17.8M
  • PT 15.8M
  • IPO Year
  • NRSN 2021
  • PT 2018
  • Fundamental
  • Price
  • NRSN $1.12
  • PT $0.99
  • Analyst Decision
  • NRSN Hold
  • PT
  • Analyst Count
  • NRSN 1
  • PT 0
  • Target Price
  • NRSN N/A
  • PT N/A
  • AVG Volume (30 Days)
  • NRSN 129.6K
  • PT 34.0K
  • Earning Date
  • NRSN 04-04-2025
  • PT 04-29-2025
  • Dividend Yield
  • NRSN N/A
  • PT N/A
  • EPS Growth
  • NRSN N/A
  • PT N/A
  • EPS
  • NRSN N/A
  • PT N/A
  • Revenue
  • NRSN N/A
  • PT $4,479,352.00
  • Revenue This Year
  • NRSN N/A
  • PT N/A
  • Revenue Next Year
  • NRSN N/A
  • PT N/A
  • P/E Ratio
  • NRSN N/A
  • PT N/A
  • Revenue Growth
  • NRSN N/A
  • PT N/A
  • 52 Week Low
  • NRSN $0.51
  • PT $0.71
  • 52 Week High
  • NRSN $2.25
  • PT $1.19
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.47
  • PT 49.60
  • Support Level
  • NRSN $0.96
  • PT $0.94
  • Resistance Level
  • NRSN $1.17
  • PT $1.03
  • Average True Range (ATR)
  • NRSN 0.08
  • PT 0.08
  • MACD
  • NRSN 0.00
  • PT -0.00
  • Stochastic Oscillator
  • NRSN 66.24
  • PT 47.06

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

Share on Social Networks: